Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

34 results about "Glutamic acid diethyl ester" patented technology

L-Glutamic acid diethyl ester hydrochloride 97% CAS Number 1118-89-4. Linear Formula C 2 H 5 OCOCH 2 CH 2 CH(NH 2)COOC 2 H 5 · HCl . Molecular Weight 239.70 . Beilstein Registry Number 3597595 . EC Number 214-270-4. MDL number MFCD00012509. PubChem Substance ID 24858729. SDS FTNMR (PDF) Similar Products.

New synthesis technology of anti-cancer drug Raltitrexed

The invention relates to a new synthesis technology of anti-cancer drug Raltitrexed. The technology comprises the following steps: 1) using L-glutamic acid as raw material to perform esterification with alcohol under the action of halogenating agent and obtain L-glutamic acid diester hydrochloride; 2) using 2-amino-5-methyl-benzoic acid as raw material to prepare 6-bromomethyl-3,4-dihydro-2-methyl-4-oxo-6-quinazoline through cyclization, amination and bromination; 3) using 2-thienyl-propanedioic acid as raw material to prepare N-[5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thenoyl]-L-glutamic acid diethyl ester through nitrification, esterification, reduction, amino protection, N-methylation and device-esterification; 4) using L-glutamic acid diester hydrochloride and N-[5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thenoyl]-L-glutamic acid diethyl ester to prepare N-[5-(N-methylamino)-2-thenoyl]-L-glutamic acid diester through dehydrant condensation and deamination protection; and 5) using N-[5-(N-methylamino)-2-thenoyl]-L-glutamic acid diester and 6-bromomethyl-3,4-dihydro-2-methyl-4-oxo-6-quinazoline to perform condensation under the catalysis of alkali, recycling preparative chromatography, purifying, and performing de-esterification to obtain Raltitrexed.
Owner:深圳市普迈达科技有限公司

Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby

The invention relates to an intermediate of pemetrexed disodium, a preparation method thereof and a method for preparing pemetrexed disodium thereby; and the intermediate is (2-(4-(3-(2,4-diamino-6-oxy-1,6-dihydro-pyridine-5-group)-3-(1,3)dioxolane-2-group-propyl) benzylamine)sodium glutaric acid. The synthesis of the intermediate comprises the following steps: firstly, condensation reaction is conducted on 4-bromobenzoic acid or 4-iodobenzoic acid and L-glutamate diethylester, then Hack reaction is conducted, 4-bromo is replaced and 4-butyraldehyde is formed, then selective bromo replacement is conducted and the 4-butyladehyde is converted into 2-bromobutyraldehyde, and then condensation reaction of aldehyde and ethylene glycol is utilized for protecting the aldehyde, and pyrimidine ring is further synthesized, and finally the intermediate is obtained. Acid hydrolysis ring-closing reaction and sodium hydroxide salification are respectively conducted for once on the intermediate so as to obtain the pemetrexed disodium. The method for preparing pemetrexed disodium in the invention has high yield, low cost and easy operation and is applicable to industrialized production.
Owner:山东立新制药有限公司

Diethyl 4(4-oxobutyl) benzoyl-L-glutamate and its preparation and use

The present invention relates to new compound diethyl 4-(4-oxobutyl) benzoyl-L-glutamate and its preparation process and application. The compound diethyl 4-(4-oxobutyl) benzoyl-L-glutamate in the chemical expression as shown is prepared through the reaction of compound diethyl 4-bromo benzoyl-L-glutamate and 3-butene-1-alcohol inside Nú¼N-dimethyl formamide solvent under the action of palladium acetate catalyst, weak alkali reagent, lithium halide and phase transfer catalyst in the protection of inert gas at 50-70 deg.c. The compound diethyl 4-(4-oxobutyl) benzoyl-L-glutamate is used in synthesizing diethyl 4-[(4-oxo-3-bromo) butyl] benzoyl-L-glutamate as the intermediate of Pemetrexed disodium. The present invention results in shortened Pemetrexed disodium synthesizing path and lowered production cost.
Owner:ZHEJIANG UNIV OF TECH

Improved process of preparing Raltitrexed

The improvement in the process of preparing Raltitrexed as antitumor medicine includes the reaction between N-(5-aminothienyl-2-formoxyl)-L-diethyl glutarate and methyl iodide at temperature raised to 100 deg.c in lucifugous condition with yield raised to 91 %; the replacement of sodium sulfide for iron powder as reductant to facilitate post-treatment and raise yield; the replacement of re-crystallization in mixed solvent of methanol and ether for column separation to expand the production capacity; and oxidizing 5-nitrothienyl-2-formaldehyde with chromic acid, rather than bromine, to eliminate toxicity and raise safety. The improved preparation process of Raltitrexed has high yield, great production capacity, low solvent consumption and high safety.
Owner:魏秀华

Preparation method of chiral MOF supermolecule composite material and application of such material in identification of penicillamine enantiomer

The invention discloses a preparation method of a chiral MOF supermolecule composite material and an application of such material in efficient electrochemical identification of a penicillamine enantiomer and belongs to the technical field of nanomaterials, electrochemical chiral recognition and metal organic frame materials. The method mainly comprises the following steps: synthesizing a chiral L-glutamic acid bolaamphiphile L-HDGA by using hexadecyl diacid and diethyl glutamate, and then, preparing a spirally-arranged L-HDGA template with ethanol and water as solvents; and through a self-assembly method, preparing the composite material with ZIF 67 nanoparticles loaded on the surface of the L HDGA spiral structure. The application of the material in efficient electrochemical identification of the penicillamine enantiomer has the advantages of simple process, fast response and wide electrochemical identification; and the material has an application prospect.
Owner:UNIV OF JINAN

Radioactive composition as well as one-time radioactive synthesis method and application thereof

The invention relates to composition (a compound molecular probe preparation) containing various radioactive compounds such as <18>F-FDG (<18>F-fludeoxyglucose), <18>F-FPA (2-<18>F-fluoropropionic acid) and / or <18>F-NFPGlu ((N-2-<18>F-fluoropropionyl)-L-alpha-glutamic acid), a one-time radioactive synthesis method of the composition and an application of the composition in preparation of positron emission computed tomography drugs. The composition comprising <18>F-FDG+<18>F-FPA and <18>F-FDG+<18>F-NFPGlu or <18>F-FDG+<18>F-FPA+<18>F-NFPGlu as PET drugs can be obtained from precursors through nucleophilic fluorination reaction and a hydrolysis reaction, wherein the precursors comprise a mannose triflate and ethyl 2-bromopropionate mixture and a mannose triflate and (N-2-bromopropionyl)-L-alpha-diethyl glutamate mixture or a mixture of mannose triflate, ethyl 2-bromopropionate and (N-2-bromopropionyl)-L-alpha-diethyl glutamate. The composition can be used for differential diagnosis and therapeutic effect evaluation of tumor, cardiovascular and cerebrovascular diseases and nervous and mental diseases and can overcome limitation of <18>F-FDG.
Owner:GUANGDONG HUIXUAN PHARMA TECH

Preparation method of pemetrexed disodium

The invention discloses a preparation method of pemetrexed disodium, which can directly hydrolyzing into salt after an organic solvent is removed, rather than salifying together with p-toluenesulfonic acid and / or purifying a product by adopting a crystallization method during the preparation process, thus omitting the step of salifying together with p-toluenesulfonic acid and / or crystallization through ethanol, effectively improving the total yield of drugs to 68-75%; in the preparation process, a peptide condensing agent is firstly prepared and is fully reacted with pemedolac in the organic solvent into transient-state acid ester, so that the generation of N-methylation impurities can be effectively inhibited in the reaction together with L-glutamic acid diethyl ester hydrochloride, the defect that the content of N-methylation impurities during the one-pot preparation process in the prior art exceeds 0.1% can be avoided, the advantages for opening up Europe and America markets can be brought, the defect that the raw materials are not reacted thoroughly to cause high cost can also be overcome; the HPLC (High Performance Liquid Chromatograph) of the finished pemetrexed disodium obtained by adopting the method is more than or equal to 99.8%, and the content of single impurities is less than 0.1%.
Owner:NINGBO MENOVO PHARMA

Gas chromatography detection method of chloroethane in L-glutamic acid diethyl ester hydrochloride

The invention discloses a gas chromatography detection method of chloroethane in L-glutamic acid diethyl ester hydrochloride. A L-glutamic acid diethyl ester hydrochloride sample is dissolved and thenheadspace sample injection is performed. A GC-ECD detection method is used to carry out qualitative and quantitative operation on the chloroethane in the L-glutamic acid diethyl ester hydrochloride and methodology validation is performed. The method has the advantages of high specificity, a rapid speed, sensitive performance and the like. In the invention, the method of carrying out qualitative and quantitative operation on the chloroethane in the L-glutamic acid diethyl ester hydrochloride through adopting the GC-ECD detection method is firstly established so that the quality of the L-glutamic acid diethyl ester hydrochloride can be conveniently controlled.
Owner:SHANDONG BOYUAN PHARM CO LTD

Synthesis method for Raltitrexed midbody

The invention discloses a synthesis method for a Raltitrexed midbody. The method comprises the following steps of a, pumping N-(5-amino-2-thenolyl)-L-glutamate diethyl ester and methyl iodide same in mole into a high flux-microchannel reactor from two feeding injection ports; b, placing the reactor in constant temperature water bath at 35-45 DEG C, enabling the reaction solution to react through the high-flux-microchannel reactor at a velocity of 5-13 mL/min, collecting the reaction solution at the outlet, cooling the reaction solution to a room temperature, adding water and ethyl acetate firstly in the reaction solution, and using ethyl acetate to extract the reaction solution twice, and merging organic layers; after performing alkaline hydrolysis on the water layer with anhydrous sodium carbonate, extracting the alkaline hydrolyzed water phase with ethyl acetate, merging the organic layer which is extracted by the reaction solution and the organic layer after the water layer is alkaline hydrolyzed; and drying the organic layers with anhydrous magnesium sulfate, filtering the dried organic layers, decompressing to remove the solvent, and thus obtaining the Raltitrexed midbody. The synthesis method provided by the invention is scientific and rational, the product yield and purity are high, and the method is suitable for promotion and application.
Owner:无锡紫杉药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products